Curadim Pharma Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://curadim.co.jp
A First-in-human Phase 1 Study of CP1050
Phase 1
- Conditions
- Healthy Subjects
- Interventions
- Drug: CP1050 or Placebo
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2018-03-16
- Lead Sponsor
- Curadim Pharma Co., Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT03468413
- Locations
- 🇬🇧
Covance Clinical Research Unit (CRU) Ltd., Leeds, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath